The FDA has issued a safety alert regarding the use of fecal microbiota for transplantation, or FMT, following reports of two adults who received the investigational FMT developing invasive infections caused by extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (E.coli).
The FDA has pulled up Scottsdale, Arizona-based R3 Stem Cell LLC for marketing
unapproved stem cell products for treating serious health conditions.